Supplement: NJ A4052 | 2022-2023 | Regular Session | Statement AHE 6/5/23

For additional supplements on New Jersey A4052 please see the Bill Drafting List
Bill Title: Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.

Status: 2024-01-08 - Approved P.L.2023, c.242. [A4052 Detail]

Download: New_Jersey-2022-A4052-Statement_AHE_6-5-23.pdf
It appears your computer is unable to display this document, however you can Download New_Jersey-2022-A4052-Statement_AHE_6-5-23.pdf here.
feedback